This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Death of a Cannabis Salesman

NEW YORK (MainStreet) — Having spent some time exploring the marijuana dispensaries in Colorado, I can't help but notice how inefficient they truly are. Some feel like you're entering a secret spy base in an alley, while others look like convenience stores that are going out of business.

Whether for recreational or medicinal use, cannabis sells itself. The staff in these buildings are, albeit knowledgeable about their product, are really tertiary elements to the transaction. This, paired with the most dubious and discriminatory pricing policies, the federal decriminalization of marijuana will be a boon to everyone in the marijuana industry – except dispensaries.


Once large corporations can sink their money into the marijuana industry, the entire selection and inventory of any dispensary will become a mini-endcap on the counter next to the vaporizers and e-cigarettes. These hidden locations will be competing with every 7-Eleven, Wal-Mart, gas station and grocery store.

At that point in time, people looking for a more personalized experience can simply make a purchase in the marijuana room of any smoke or head shop in the country. What it boils down to is these dispensaries won't be able to compete with companies that use every inch of their stores to entice purchases.

Lemon-Aid Stand

Even if you live in a state where marijuana isn't available recreationally, federal decriminalization will make THC- and CBD- extracts available in pharmacies. Once again, the dispensaries are lemonade stands compared to pharmacy retail giants like CVS and Walgreens.

There are so many strains of cannabis available in so many forms that these dispensaries will end up looking as kitschy as an oxygen bar in a Vegas casino. The edibles companies already in full production these days is astounding. Growers are looking to unload bulk product. The efficiency of these archaic brick and mortar representations of the cannabis movement render them unsustainable.

Growing Pains

At this point in the legalization process, even opening one dispensary is a financial accomplishment. Some investment groups have been able to swing multiple locations. These early pioneers will make a profit off pot tourism, but this is only bound to last until federal decriminalization.

Also See: Carolinas Eye Cannabinoid Reform Warily

Distribution across state borders will then become legal, and once again, giants like Wal-Mart have a much larger distribution system in place. At that point, even Amazon, (or, the Amazon of Pot that pops up in its absence) will have a shot at delivery.

A dispensary that creates its own strands has a chance to sell its products through these channels, but they'd be nothing more than another wine bottle on the shelf of some conglomerate liquor store.

Nappy Valley

Marijuana penny stocks have become a legislative hot button, and banks are still balking at lending money to cannabis-related businesses. Reports out of both Colorado and Washington show a sentiment of positivity at the legal sale of marijuana; however, most prefer to purchase it from friends.

Also See: GWPH Pot Stock Continues to Soar

Despite these challenges, entrepreneurs, investors, and early adopters eagerly keep their eye on the budding industries in Colorado and Washington. There are thousands of great small businesses across the country succeeding in the pot trade. Just don't count on dispensaries to be one of them.

--Brian Penny is a former Operations Manager and Business Analyst at Bank of America turned whistleblower. He's a frequent contributor to Cannabis Now, Huffington Post, Money Side of Life, and Fast Company.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.18 1.60%
FB $117.44 -0.95%
GOOG $692.33 -0.84%
TSLA $232.12 -4.00%
YHOO $36.02 -1.40%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs